https://www.agastiyabiotech.com/media/introducing-quantum-medicine-to-the-world/ 2022-01-20T11:51:51+00:00 https://www.agastiyabiotech.com/media/vopec-gets-noc-test-license-from-dcgi-to-develop-new-cancer-drug-that-offers-therapeutic-option-for-covid-19/ 2022-01-20T12:23:43+00:00 https://www.agastiyabiotech.com/media/agastiya-biotech-usa-developing-drugs-for-stage-iv-cancer-and-covid-19/ 2022-01-20T12:29:48+00:00 https://www.agastiyabiotech.com/media/agastiya-biotech-to-bridge-u-s-india-drug-development/ 2022-01-20T12:34:59+00:00 https://www.agastiyabiotech.com/media/psoriasis-pub2018/ 2022-01-20T12:35:59+00:00 https://www.agastiyabiotech.com/media/agastiya-biotech-proceeding-with-drug-candidate-for-covid-19/ 2022-01-20T13:03:51+00:00 https://www.agastiyabiotech.com/media/agastiya-biotech-receives-fda-orphan-drug-designation-for-ab001-for-pancreatic-cancer-and-acute-myeloid-leukemia-aml/ 2022-05-04T04:14:30+00:00 https://www.agastiyabiotech.com/media/vopec-pharmaceuticals-and-agastiya-biotech-announce-breakthrough-phase-1-study-results-of-small-molecule-ab001-for-multiple-metastatic-solid-tumors/ 2024-04-05T00:07:38+00:00